Skip to Content

'
John N. Papadopoulos, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
Katy Regional Care Center
19770 Kingsland Blvd. Ste. 200
Unit Number: 1470
Houston, TX 77094
Phone: 713-563-9600
Fax: 281-646-4351
Email: jnpapado@mdanderson.org

Education & Training

Degree-Granting Education

2002 Texas Tech University School of Medicine, Lubbock, TX, MD, Medicine
1997 University of Texas, Austin, TX, BA, Business Administration in Finance

Postgraduate Training

7/2007-7/2009 Clinical Fellowship, Urology Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
7/2007-7/2008 Research Fellowship, Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, Isaiah J. Fidler, DVM, PhD
7/2004-7/2007 Clinical Residency, General, University of Wisconsin Hospital and Clinics, Madison, WI
7/2003-7/2004 Clinical Internship, General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI

Board Certifications

2/2011 American Board of Urology

Professional Memberships

American Association of Clinical Urologists
Member, 2011-present
American Medical Association
Member, 2011-present
American Urological Association
Member, 2011-present
Harris County Medical Society
Member, 2011-present
Texas medical Association
Member, 2011-present

Selected Publications

Invited Articles
1. Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, Zhang F, He J, Fan D, Langley R, Fidler IJ. Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am J Pathol 174(5):1972-80, 5/2009. e-Pub 4/6/2009. PMCID: PMC2671284.
2. Kaplon D, Jarrard DF, Papadopoulos JN. Urothelial Tumors of the Renal Pelvis and Ureters. eMedicine, eMedicine, 3/2009.
3. Mathew P, Pisters LL, Wood CG, Papadopoulos JN, Williams DL, Thall PF, Wen S, Horne E, Oborn CJ, Langley R, Fidler IJ, Pettaway CA. Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer. J Urol 181(1):81-7; discussion 87, 1/2009. e-Pub 11/13/2008. PMID: 19012911.
4. Shaw A, Papadopoulos J, Johnson C, Bushman W. Isolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line. Prostate 66(13):1347-58, 9/15/2006. PMCID: PMC2802279.

Last updated: 10/15/2012